ProQR Announces Expert Perspectives Conference Call Series Press release … pigmentosa and ProQR’s RNA oligonucleotide platform and Axiomer RNA editing approaches. Event Details Date/Time: June … juni 12, 2020
ProQR to Present at the Retinal Cell and Gene Therapy Innovation Summit and the Association for Research in Vision and Ophthalmology (ARVO) 2022 Press release … is pioneering a next-generation RNA technology called Axiomer ® , which uses a cell’s own editing machinery called … april 26, 2022
ProQR Announces Presentations and Investor & Analyst Event at the North American Cystic Fibrosis Conference Press release … Class I) mutations in the CFTR gene using the Company’s Axiomer ® technology platform, and provide an update on other … oktober 24, 2017
ProQR Announces Positive Top-Line Results from a Phase 1b Study of QR-010 in Subjects with Cystic Fibrosis Press release … intends to target these mutations using its proprietary Axiomer ® technology, which has shown compelling data in … september 25, 2017
ProQR Reports Fourth Quarter and Full Year 2018 Operating and Financial Results Press release … develop any new product candidates, including through our Axiomer ® platform, that prior results observed from … februari 27, 2019